Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3

UK CHIC Study Group; Kholoud Porter; Sarah Walker; Teresa Hill; Jane Anderson; Clifford Leen; Margaret Johnson; Brian Gazzard; John Walsh; Martin Fisher; Chloe Orkin; Achim Schwenk; Richard Gilson; Philippa Easterbrook; Valerie Delpech; Caroline A Sabin

doi:10.1097/QAI.0b013e31815b1291

Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3

UK CHIC Study Group, Kholoud Porter, Sarah Walker, Teresa Hill, Jane Anderson, Clifford Leen, Margaret Johnson, Brian Gazzard, John Walsh, Martin Fisher, Chloe Orkin, Achim Schwenk, Richard Gilson, Philippa Easterbrook, Valerie Delpech, Caroline A Sabin

College of Medicine and Veterinary Medicine

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

Although HIV treatment guidelines recommend highly active antiretroviral therapy (HAART) initiation before reaching a CD4 count of 200 cells/mm3, many people in resource-rich settings, and a substantial proportion in resource-limited settings, present at levels

Original language	English
Pages (from-to)	202-5
Number of pages	4
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	47
Issue number	2
DOIs	https://doi.org/10.1097/QAI.0b013e31815b1291
Publication status	Published - 1 Feb 2008

Keywords / Materials (for Non-textual outputs)

Adult
Age Factors
Anti-HIV Agents
Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
Female
Great Britain
HIV Infections
Humans
Male
Sex Factors
Treatment Outcome
Viral Load

Access to Document

10.1097/QAI.0b013e31815b1291

Cite this

UK CHIC Study Group, Porter, K., Walker, S., Hill, T., Anderson, J., Leen, C., Johnson, M., Gazzard, B., Walsh, J., Fisher, M., Orkin, C., Schwenk, A., Gilson, R., Easterbrook, P., Delpech, V., & Sabin, C. A. (2008). Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3. Journal of Acquired Immune Deficiency Syndromes, 47(2), 202-5. https://doi.org/10.1097/QAI.0b013e31815b1291

@article{a3d71d67c0a34e0899c9348e194d1c85,

title = "Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3",

abstract = "Although HIV treatment guidelines recommend highly active antiretroviral therapy (HAART) initiation before reaching a CD4 count of 200 cells/mm3, many people in resource-rich settings, and a substantial proportion in resource-limited settings, present at levels ",

keywords = "Adult, Age Factors, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Female, Great Britain, HIV Infections, Humans, Male, Sex Factors, Treatment Outcome, Viral Load",

author = "{UK CHIC Study Group} and Kholoud Porter and Sarah Walker and Teresa Hill and Jane Anderson and Clifford Leen and Margaret Johnson and Brian Gazzard and John Walsh and Martin Fisher and Chloe Orkin and Achim Schwenk and Richard Gilson and Philippa Easterbrook and Valerie Delpech and Sabin, {Caroline A}",

year = "2008",

month = feb,

day = "1",

doi = "10.1097/QAI.0b013e31815b1291",

language = "English",

volume = "47",

pages = "202--5",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

publisher = "Lippincott Williams & Wilkins Ltd.",

number = "2",

}

UK CHIC Study Group, Porter, K, Walker, S, Hill, T, Anderson, J, Leen, C, Johnson, M, Gazzard, B, Walsh, J, Fisher, M, Orkin, C, Schwenk, A, Gilson, R, Easterbrook, P, Delpech, V & Sabin, CA 2008, 'Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3', Journal of Acquired Immune Deficiency Syndromes, vol. 47, no. 2, pp. 202-5. https://doi.org/10.1097/QAI.0b013e31815b1291

TY - JOUR

T1 - Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3

AU - UK CHIC Study Group

AU - Porter, Kholoud

AU - Walker, Sarah

AU - Hill, Teresa

AU - Anderson, Jane

AU - Leen, Clifford

AU - Johnson, Margaret

AU - Gazzard, Brian

AU - Walsh, John

AU - Fisher, Martin

AU - Orkin, Chloe

AU - Schwenk, Achim

AU - Gilson, Richard

AU - Easterbrook, Philippa

AU - Delpech, Valerie

AU - Sabin, Caroline A

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Although HIV treatment guidelines recommend highly active antiretroviral therapy (HAART) initiation before reaching a CD4 count of 200 cells/mm3, many people in resource-rich settings, and a substantial proportion in resource-limited settings, present at levels

AB - Although HIV treatment guidelines recommend highly active antiretroviral therapy (HAART) initiation before reaching a CD4 count of 200 cells/mm3, many people in resource-rich settings, and a substantial proportion in resource-limited settings, present at levels

KW - Adult

KW - Age Factors

KW - Anti-HIV Agents

KW - Antiretroviral Therapy, Highly Active

KW - CD4 Lymphocyte Count

KW - Female

KW - Great Britain

KW - HIV Infections

KW - Humans

KW - Male

KW - Sex Factors

KW - Treatment Outcome

KW - Viral Load

U2 - 10.1097/QAI.0b013e31815b1291

DO - 10.1097/QAI.0b013e31815b1291

M3 - Article

C2 - 17971709

SN - 1525-4135

VL - 47

SP - 202

EP - 205

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

IS - 2

ER -

Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3

Abstract / Description of output

Keywords / Materials (for Non-textual outputs)

Access to Document

Fingerprint

Cite this